Page last updated: 2024-10-15

phosphoserine and Disease Models, Animal

phosphoserine has been researched along with Disease Models, Animal in 52 studies

Phosphoserine: The phosphoric acid ester of serine.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"Various evidences have documented that the pineal secretory product melatonin exerts an important anti-inflammatory effect in different experimental models including colitis."7.73Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. ( Crisafulli, C; Cuzzocrea, S; Di Bella, P; Esposito, E; Mazzon, E; Meli, R; Muià, C; Riccardi, L, 2006)
"The potential anticonvulsant effect of group III metabotropic glutamate receptor (mGluR) agonist (R,S)-4-phosphonophenylglycine ((R,S)-PPG) against seizures induced in immature 12-day-old rats by bilateral intracerebroventricular (icv) infusion of DL-homocysteic acid (DL-HCA, 600 nmol/side) was examined in the present study."7.72Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine. ( Folbergrová, J; Haugvicová, R; Mares, P, 2003)
"Treatment with melatonin (15 mg/kg daily i."5.33Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. ( Crisafulli, C; Cuzzocrea, S; Di Bella, P; Esposito, E; Mazzon, E; Meli, R; Muià, C; Riccardi, L, 2006)
"Colitis was induced by intracolonic instillation of dinitrobenzene sulfonic acid (DNBS)."5.33Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. ( Crisafulli, C; Cuzzocrea, S; Di Bella, P; Esposito, E; Mazzon, E; Meli, R; Muià, C; Riccardi, L, 2006)
"Generalized clonic-tonic seizures were completely suppressed and cortical energy metabolite changes which normally accompany these seizures were either normalized (glucose and glycogen decreases) or markedly ameliorated (an accumulation of lactate)."5.32Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine. ( Folbergrová, J; Haugvicová, R; Mares, P, 2003)
" Effects of intrathecal glutamate transporter activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline and inhibitors (DL-threo-β-benzyloxyaspartate [TBOA], dihydrokainate, and DL-threo-β-hydroxyaspartate), or TBOA plus group III metabotropic glutamate receptor antagonist (RS)-α-methylserine-O-phosphate, on formalin- and CFA-induced inflammatory pain were examined."3.77Effect of inhibition of spinal cord glutamate transporters on inflammatory pain induced by formalin and complete Freund's adjuvant. ( Guan, X; Lu, W; Petralia, RS; Rothstein, JD; Tao, YX; Yaster, M, 2011)
"In this study, the effect of (S)-3,4-dicarboxyphenylglycine (DCPG), a selective mGlu8 receptor agonist, has been investigated in inflammatory and neuropathic pain models in order to elucidate the role of mGlu8 receptor in modulating pain perception."3.74Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice. ( de Novellis, V; Maione, S; Marabese, I; Palazzo, E; Rossi, F; Scafuro, MA; Vita, D, 2007)
"Various evidences have documented that the pineal secretory product melatonin exerts an important anti-inflammatory effect in different experimental models including colitis."3.73Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. ( Crisafulli, C; Cuzzocrea, S; Di Bella, P; Esposito, E; Mazzon, E; Meli, R; Muià, C; Riccardi, L, 2006)
"The potential anticonvulsant effect of group III metabotropic glutamate receptor (mGluR) agonist (R,S)-4-phosphonophenylglycine ((R,S)-PPG) against seizures induced in immature 12-day-old rats by bilateral intracerebroventricular (icv) infusion of DL-homocysteic acid (DL-HCA, 600 nmol/side) was examined in the present study."3.72Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine. ( Folbergrová, J; Haugvicová, R; Mares, P, 2003)
"Heritable nephrogenic diabetes insipidus (NDI) is characterized by defective urine concentration mechanisms in the kidney, which are mainly caused by loss-of-function mutations in the vasopressin type 2 receptor."1.43Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. ( Ando, F; Kikuchi, E; Kondo, Y; Mori, T; Morimoto, T; Nomura, N; Rai, T; Sasaki, S; Sohara, E; Takahashi, D; Uchida, S; Vandewalle, A; Yui, N, 2016)
"Conversely, Tnfr1(-/-)Tag-expressing cancers resist cytokine-induced senescence and grow aggressively, even in TNFR1-expressing hosts."1.39T-helper-1-cell cytokines drive cancer into senescence. ( Alkhaled, M; Aßmann, S; Bauer, J; Berdel, J; Braumüller, H; Braungart, K; Brenner, E; Essmann, F; Fehrenbacher, B; Fend, F; Griessinger, C; Hahn, M; Handgretinger, R; Häring, HU; Kneilling, M; Mehra, T; Meier, F; Mocikat, R; Niessner, H; Pesic, M; Quintanilla-Martinez, L; Ranta, F; Röcken, M; Schaller, M; Schilbach, K; Schulze-Osthoff, K; Ullrich, S; van den Broek, M; Wieder, T; Zender, L, 2013)
"The mechanisms of Src implication in cancer and inflammation are linked to the ability of activated Src to phosphorylate multiple downstream targets that mediate its cellular effector functions."1.36Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells. ( Abdel Fattah, E; Eissa, NT; Gorgun, FM; Mazumdar, T; Pandit, L; Tyryshkin, A; Zeng, S, 2010)
"Hemostasis and thrombosis are regulated by agonist-induced activation of platelet integrin alpha(IIb)beta(3)."1.35The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function. ( Alrehani, N; Cruz, MA; Gushiken, FC; Hyojeong, H; Langlois, KW; Pradhan, S; Rumbaut, RE; Vijayan, KV, 2009)
"Accordingly, type 2 diabetes characterized by insulin resistance is associated with an increased risk of developing Alzheimer's disease."1.33Peripheral hyperinsulinemia promotes tau phosphorylation in vivo. ( Bruning, JC; Freude, S; Krone, W; Leeser, U; Plum, L; Schnitker, J; Schubert, M; Udelhoven, M, 2005)
"Treatment with melatonin (15 mg/kg daily i."1.33Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. ( Crisafulli, C; Cuzzocrea, S; Di Bella, P; Esposito, E; Mazzon, E; Meli, R; Muià, C; Riccardi, L, 2006)
"Colitis was induced by intracolonic instillation of dinitrobenzene sulfonic acid (DNBS)."1.33Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. ( Crisafulli, C; Cuzzocrea, S; Di Bella, P; Esposito, E; Mazzon, E; Meli, R; Muià, C; Riccardi, L, 2006)
"Generalized clonic-tonic seizures were completely suppressed and cortical energy metabolite changes which normally accompany these seizures were either normalized (glucose and glycogen decreases) or markedly ameliorated (an accumulation of lactate)."1.32Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine. ( Folbergrová, J; Haugvicová, R; Mares, P, 2003)

Research

Studies (52)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.92)18.7374
1990's0 (0.00)18.2507
2000's12 (23.08)29.6817
2010's35 (67.31)24.3611
2020's4 (7.69)2.80

Authors

AuthorsStudies
Wang, Y1
Yuan, J1
Yu, X2
Liu, X1
Tan, C1
Chen, Y1
Xu, T1
Foote, KM1
Lyman, KA1
Han, Y1
Michailidis, IE1
Heuermann, RJ1
Mandikian, D1
Trimmer, JS1
Swanson, GT1
Chetkovich, DM1
Kumari, R1
Kumar, R1
Kumar, S1
Singh, AK1
Hanpude, P1
Jangir, D1
Maiti, TK1
Muñoz-Lasso, DC1
Mollá, B1
Calap-Quintana, P1
García-Giménez, JL1
Pallardo, FV1
Palau, F1
Gonzalez-Cabo, P1
Martín-Flores, N1
Pérez-Sisqués, L1
Creus-Muncunill, J1
Masana, M1
Ginés, S2
Alberch, J1
Pérez-Navarro, E1
Malagelada, C1
Zhou, J1
Tien, AC1
Alberta, JA1
Ficarro, SB1
Griveau, A1
Sun, Y1
Deshpande, JS1
Card, JD1
Morgan-Smith, M1
Michowski, W1
Hashizume, R1
James, CD1
Ligon, KL1
Snider, WD1
Sicinski, P1
Marto, JA1
Rowitch, DH1
Stiles, CD1
Daldin, M1
Fodale, V1
Cariulo, C1
Azzollini, L1
Verani, M1
Martufi, P1
Spiezia, MC1
Deguire, SM1
Cherubini, M1
Macdonald, D1
Weiss, A1
Bresciani, A1
Vonsattel, JG1
Petricca, L1
Marsh, JL1
Santimone, I1
Marano, M1
Lashuel, HA1
Squitieri, F1
Caricasole, A1
Ranieri, A1
Kemp, E1
Burgoyne, JR1
Avkiran, M1
Kurano, M1
Tsuneyama, K1
Morimoto, Y1
Shimizu, T1
Jona, M1
Kassai, H1
Nakao, K1
Aiba, A1
Yatomi, Y1
Chen, J1
Ren, Y1
Gui, C1
Zhao, M1
Wu, X1
Mao, K1
Li, W1
Zou, F1
Kawa, Y1
Nagano, T1
Yoshizaki, A1
Dokuni, R1
Katsurada, M1
Terashita, T1
Yasuda, Y1
Umezawa, K1
Yamamoto, M1
Kamiryo, H1
Kobayashi, K1
Nishimura, Y1
Ma, C1
Tian, X1
Kim, JP1
Xie, D1
Ao, X1
Shan, D1
Lin, Q1
Hudock, MR1
Bai, X1
Yang, J1
Cavallucci, V1
Berretta, N1
Nobili, A1
Nisticò, R1
Mercuri, NB1
D'Amelio, M1
Contín, MA1
Arietti, MM1
Benedetto, MM1
Bussi, C1
Guido, ME1
Fathallah, AM1
Ramakrishnan, R1
Balu-Iyer, SV2
Ozmen, L1
Collin, L1
Liu, SB1
Zhang, MM1
Cheng, LF1
Shi, J1
Lu, JS1
Zhuo, M1
Ando, K1
Oka, M1
Ohtake, Y1
Hayashishita, M1
Shimizu, S1
Hisanaga, S1
Iijima, KM1
Hasegawa, Y1
Uekawa, K1
Kawano, T1
Suzuki, H1
Kim-Mitsuyama, S1
Dai, X1
Ding, Y1
Liu, Z1
Zhang, W1
Zou, MH1
Ando, F1
Sohara, E1
Morimoto, T1
Yui, N1
Nomura, N1
Kikuchi, E1
Takahashi, D1
Mori, T1
Vandewalle, A1
Rai, T1
Sasaki, S1
Kondo, Y1
Uchida, S1
Zhuang, N1
Li, L1
Chen, S1
Wang, T1
Ye, Y1
Zhao, Z1
Xu, H2
Zhang, X1
Su, X1
Yang, Y1
He, X1
Dolan, S1
Gunn, MD1
Biddlestone, L1
Nolan, AM1
Tyryshkin, A1
Gorgun, FM1
Abdel Fattah, E1
Mazumdar, T1
Pandit, L1
Zeng, S1
Eissa, NT1
Gushiken, FC1
Hyojeong, H1
Pradhan, S1
Langlois, KW1
Alrehani, N1
Cruz, MA1
Rumbaut, RE1
Vijayan, KV1
Iijima, K1
Gatt, A1
Iijima-Ando, K1
Xin-Long, C1
Zhao-Fan, X1
Dao-Feng, B1
Wei, D1
Austin, PJ1
Betts, MJ1
Broadstock, M1
O'Neill, MJ1
Mitchell, SN1
Duty, S1
Sofola, O1
Kerr, F1
Rogers, I1
Killick, R1
Augustin, H1
Gandy, C1
Allen, MJ1
Hardy, J1
Lovestone, S1
Partridge, L1
Yaster, M1
Guan, X1
Petralia, RS1
Rothstein, JD1
Lu, W1
Tao, YX1
Beurel, E1
Song, L1
Jope, RS1
Roy, D1
Dittmer, DP1
Choi, JH1
Banks, AS1
Kamenecka, TM1
Busby, SA1
Chalmers, MJ1
Kumar, N1
Kuruvilla, DS1
Shin, Y1
He, Y1
Bruning, JB1
Marciano, DP1
Cameron, MD1
Laznik, D1
Jurczak, MJ1
Schürer, SC1
Vidović, D1
Shulman, GI1
Spiegelman, BM1
Griffin, PR1
Coffee, RL1
Williamson, AJ1
Adkins, CM1
Gray, MC1
Page, TL1
Broadie, K1
Wang, P1
Guan, YF1
Du, H1
Zhai, QW1
Su, DF1
Miao, CY1
Vera, G1
Tapia, R1
Di Pardo, A1
Maglione, V1
Alpaugh, M1
Horkey, M1
Atwal, RS1
Sassone, J1
Ciammola, A1
Steffan, JS1
Fouad, K1
Truant, R1
Sipione, S1
Duran, JM1
Taghavi, S1
Berretta, RM1
Makarewich, CA1
Sharp Iii, T1
Starosta, T1
Udeshi, F1
George, JC1
Kubo, H1
Houser, SR1
Krolikowski, JG1
Jones, DW1
Ge, ZD1
Pagel, PS1
Pritchard, KA1
Weihrauch, D1
Braumüller, H1
Wieder, T1
Brenner, E1
Aßmann, S1
Hahn, M1
Alkhaled, M1
Schilbach, K1
Essmann, F1
Kneilling, M1
Griessinger, C1
Ranta, F1
Ullrich, S1
Mocikat, R1
Braungart, K1
Mehra, T1
Fehrenbacher, B1
Berdel, J1
Niessner, H1
Meier, F1
van den Broek, M1
Häring, HU1
Handgretinger, R1
Quintanilla-Martinez, L1
Fend, F1
Pesic, M1
Bauer, J1
Zender, L1
Schaller, M1
Schulze-Osthoff, K1
Röcken, M1
Osuka, K2
Watanabe, Y2
Usuda, N2
Nakazawa, A2
Fukunaga, K1
Miyamoto, E1
Takayasu, M1
Tokuda, M2
Yoshida, J2
Folbergrová, J1
Haugvicová, R1
Mares, P1
Musicki, B1
Kramer, MF1
Becker, RE1
Burnett, AL1
Freude, S1
Plum, L1
Schnitker, J1
Leeser, U1
Udelhoven, M1
Krone, W1
Bruning, JC1
Schubert, M1
Yamauchi, K1
Brunner, TB1
Ernst-Stecken, A1
Jeske, I1
Grabenbauer, GG1
Sauer, R1
Distel, L1
Mazzon, E1
Esposito, E1
Crisafulli, C1
Riccardi, L1
Muià, C1
Di Bella, P1
Meli, R1
Cuzzocrea, S1
Marabese, I1
de Novellis, V1
Palazzo, E1
Scafuro, MA1
Vita, D1
Rossi, F1
Maione, S1
Miclea, RD1
Purohit, VS1
Schweigreiter, R1
Stasyk, T1
Contarini, I1
Frauscher, S1
Oertle, T1
Klimaschewski, L1
Huber, LA1
Bandtlow, CE1
Glimcher, MJ1
Reit, B1
Kossiva, D1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis[NCT02737202]Phase 228 participants (Actual)Interventional2016-04-30Terminated
Evaluation of the Initial Prescription of Ketamine and Milnacipran Forin Depression in Patients With a Progressive Disease[NCT02783430]Phase 2/Phase 380 participants (Anticipated)Interventional2016-09-08Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

52 other studies available for phosphoserine and Disease Models, Animal

ArticleYear
Vezatin regulates seizures by controlling AMPAR-mediated synaptic activity.
    Cell death & disease, 2021, 10-12, Volume: 12, Issue:10

    Topics: Animals; Carrier Proteins; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Epilepsy; E

2021
Phosphorylation of the HCN channel auxiliary subunit TRIP8b is altered in an animal model of temporal lobe epilepsy and modulates channel function.
    The Journal of biological chemistry, 2019, 10-25, Volume: 294, Issue:43

    Topics: Amino Acid Sequence; Animals; Brain; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dendrites;

2019
Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.
    The Journal of biological chemistry, 2020, 03-13, Volume: 295, Issue:11

    Topics: Actin Cytoskeleton; alpha-Synuclein; Amyloid; Animals; Apoptosis; Cell Death; Cell Line, Tumor; Comp

2020
Cofilin dysregulation alters actin turnover in frataxin-deficient neurons.
    Scientific reports, 2020, 03-23, Volume: 10, Issue:1

    Topics: Actin Cytoskeleton; Actin-Related Protein 2-3 Complex; Actins; Animals; Axons; Cells, Cultured; Cofi

2020
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.
    Cell death & disease, 2020, 07-30, Volume: 11, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cells, Cultured; Cerebral Cortex; Corpus Striatum; De

2020
A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.
    Cell reports, 2017, 03-28, Volume: 18, Issue:13

    Topics: Animals; Carcinogenesis; Casein Kinase II; Cell Line, Tumor; Cyclin-Dependent Kinases; Disease Model

2017
Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.
    Scientific reports, 2017, 07-11, Volume: 7, Issue:1

    Topics: Animals; Brain; Disease Models, Animal; Drosophila; Exons; Fibroblasts; HEK293 Cells; Humans; Huntin

2017
β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.
    Journal of molecular and cellular cardiology, 2018, Volume: 115

    Topics: Adenoviridae; Adrenergic beta-Agonists; Amino Acid Sequence; Animals; Cardiomegaly; Disease Models,

2018
Apolipoprotein M Protects Lipopolysaccharide-Treated Mice from Death and Organ Injury.
    Thrombosis and haemostasis, 2018, Volume: 118, Issue:6

    Topics: Alanine Transaminase; Animals; Apolipoproteins M; Clustered Regularly Interspaced Short Palindromic

2018
Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
    Cell death & disease, 2018, 06-13, Volume: 9, Issue:6

    Topics: alpha-Synuclein; Animals; Apoptosis; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Enzyme

2018
Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Cell Line; Chemokine CCL20; Disease Models, Anim

2018
Citrate-based materials fuel human stem cells by metabonegenic regulation.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 12-11, Volume: 115, Issue:50

    Topics: Adenosine Triphosphate; Animals; Biocompatible Materials; Biopolymers; Bone Regeneration; Cell Adhes

2018
Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease.
    Neuromolecular medicine, 2013, Volume: 15, Issue:3

    Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Calcineurin Inhibitors; Caspase 3; Dendrites; D

2013
Photoreceptor damage induced by low-intensity light: model of retinal degeneration in mammals.
    Molecular vision, 2013, Volume: 19

    Topics: Animals; Annexin A5; Caspase 3; Cell Death; Disease Models, Animal; In Situ Nick-End Labeling; Light

2013
O-phospho-l-serine mediates hyporesponsiveness toward FVIII in hemophilia A-murine model by inducing tolerogenic properties in dendritic cells.
    Journal of pharmaceutical sciences, 2014, Volume: 103, Issue:11

    Topics: Adjuvants, Immunologic; Animals; Antibodies; CD40 Antigens; Cells, Cultured; Coagulants; Dendritic C

2014
[Passive Tau immunotherapy for prevention of Tau pathology progression].
    Medecine sciences : M/S, 2015, Volume: 31, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Disease Models, Animal; Disease Progression;

2015
Long-term upregulation of cortical glutamatergic AMPA receptors in a mouse model of chronic visceral pain.
    Molecular brain, 2015, Nov-19, Volume: 8, Issue:1

    Topics: Adamantane; Adenylyl Cyclases; Animals; Behavior, Animal; Calcium; Cell Membrane; Chronic Pain; Dise

2015
Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.
    Biochemical and biophysical research communications, 2016, 09-16, Volume: 478, Issue:2

    Topics: Alzheimer Disease; Amino Acid Substitution; Animals; Disease Models, Animal; Drosophila melanogaster

2016
Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage.
    Current drug delivery, 2017, Sep-06, Volume: 14, Issue:6

    Topics: Animals; Brain; Brain Edema; Disease Models, Animal; Fingolimod Hydrochloride; Male; Neuroprotective

2017
Phosphorylation of CHOP (C/EBP Homologous Protein) by the AMP-Activated Protein Kinase Alpha 1 in Macrophages Promotes CHOP Degradation and Reduces Injury-Induced Neointimal Disruption In Vivo.
    Circulation research, 2016, Oct-28, Volume: 119, Issue:10

    Topics: AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Apoptosis; Carotid Artery, Common; Caroti

2016
Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
    Nature communications, 2016, 11-28, Volume: 7

    Topics: Animals; Aquaporin 2; Arachidonic Acid; beta Catenin; Calcineurin; Calcium; Calcium Signaling; Cycli

2016
PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control.
    Cell death & disease, 2016, 12-01, Volume: 7, Issue:12

    Topics: Amino Acid Sequence; Animals; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins;

2016
Activation of Sphingosine 1-Phosphate Receptor 1 Enhances Hippocampus Neurogenesis in a Rat Model of Traumatic Brain Injury: An Involvement of MEK/Erk Signaling Pathway.
    Neural plasticity, 2016, Volume: 2016

    Topics: Animals; Brain Injuries, Traumatic; Disease Models, Animal; Hippocampus; Male; MAP Kinase Signaling

2016
The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat.
    Behavioural pharmacology, 2009, Volume: 20, Issue:7

    Topics: Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzhydryl Compounds; Carra

2009
Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells.
    The Journal of biological chemistry, 2010, Jan-01, Volume: 285, Issue:1

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Enzyme Activation; Enzyme Stability; Epidermal Gr

2010
The catalytic subunit of protein phosphatase 1 gamma regulates thrombin-induced murine platelet alpha(IIb)beta(3) function.
    PloS one, 2009, Dec-15, Volume: 4, Issue:12

    Topics: Animals; Blood Platelets; Catalytic Domain; Disease Models, Animal; Fibrinogen; Glycogen Synthase Ki

2009
Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease.
    Human molecular genetics, 2010, Aug-01, Volume: 19, Issue:15

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Brain; Checkpoint

2010
mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
    Burns : journal of the International Society for Burn Injuries, 2011, Volume: 37, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Blotting, Western; Burns; C-Peptide; Disease Models, Animal; Glucose

2011
Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease.
    British journal of pharmacology, 2010, Volume: 160, Issue:7

    Topics: Aminobutyrates; Animals; Aspartic Acid; Disease Models, Animal; Excitatory Amino Acid Agonists; Glut

2010
Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.
    PLoS genetics, 2010, Sep-02, Volume: 6, Issue:9

    Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Drosophil

2010
Effect of inhibition of spinal cord glutamate transporters on inflammatory pain induced by formalin and complete Freund's adjuvant.
    Anesthesiology, 2011, Volume: 114, Issue:2

    Topics: Amino Acid Transport System X-AG; Animals; Aspartic Acid; Blotting, Western; Disease Models, Animal;

2011
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.
    Molecular psychiatry, 2011, Volume: 16, Issue:11

    Topics: Amino Acid Substitution; Animals; Antidepressive Agents; Cerebral Cortex; Depression; Disease Models

2011
Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.
    The American journal of pathology, 2011, Volume: 179, Issue:4

    Topics: Animals; Biopsy; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Enzyme Activation; Hu

2011
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.
    Nature, 2011, Sep-04, Volume: 477, Issue:7365

    Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue, White; Animals; Biphenyl Compounds; Body Fluids; Chloroceb

2011
In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.
    Human molecular genetics, 2012, Feb-15, Volume: 21, Issue:4

    Topics: Animals; Animals, Genetically Modified; Brain; Cytoskeleton; Disease Models, Animal; Drosophila mela

2012
Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia.
    Autophagy, 2012, Volume: 8, Issue:1

    Topics: Adenine; Animals; Autophagy; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Glucose; Infar

2012
Activation of group III metabotropic glutamate receptors by endogenous glutamate protects against glutamate-mediated excitotoxicity in the hippocampus in vivo.
    Journal of neuroscience research, 2012, Volume: 90, Issue:5

    Topics: 4-Aminopyridine; Amino Acids; Animals; Carboxylic Acids; Chromatography, High Pressure Liquid; Disea

2012
Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Feb-28, Volume: 109, Issue:9

    Topics: Animals; Codon; Corpus Striatum; Dimerization; Disease Models, Animal; Dopamine and cAMP-Regulated P

2012
A characterization and targeting of the infarct border zone in a swine model of myocardial infarction.
    Clinical and translational science, 2012, Volume: 5, Issue:5

    Topics: Animals; Biomechanical Phenomena; Blotting, Western; Disease Models, Animal; Echocardiography; Fluor

2012
4F decreases IRF5 expression and activation in hearts of tight skin mice.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Animals; Apolipoprotein A-I; Apoptosis; Disease Models, Animal; Echocardiography; Endothelial Cells;

2012
T-helper-1-cell cytokines drive cancer into senescence.
    Nature, 2013, Feb-21, Volume: 494, Issue:7437

    Topics: Animals; Antigens, Polyomavirus Transforming; Cell Cycle; Cell Proliferation; Cellular Senescence; C

2013
Phosphorylation of neuronal nitric oxide synthase at Ser847 by CaM-KII in the hippocampus of rat brain after transient forebrain ischemia.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:9

    Topics: Animals; Benzylamines; Blood Pressure; Body Temperature; Calcium-Calmodulin-Dependent Protein Kinase

2002
Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptoragonist (R,S)-4-phosphonophenylglycine.
    Experimental neurology, 2003, Volume: 180, Issue:1

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation

2003
Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-16, Volume: 102, Issue:33

    Topics: Acetylglucosamine; Animals; Diabetes Complications; Disease Models, Animal; Enzyme Activation; Erect

2005
Peripheral hyperinsulinemia promotes tau phosphorylation in vivo.
    Diabetes, 2005, Volume: 54, Issue:12

    Topics: Animals; Brain; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Models, Animal; Hyperinsul

2005
Activation of the JAK-STAT signaling pathway in the rat basilar artery after subarachnoid hemorrhage.
    Brain research, 2006, Feb-09, Volume: 1072, Issue:1

    Topics: Animals; Basilar Artery; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Endothelium, Vascular;

2006
Molecular verification of stereotactic radiotherapy in rats using ATMpS1981 immunofluorescence.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2006, Volume: 79, Issue:1

    Topics: Animals; Brain; Brain Chemistry; Brain Neoplasms; Disease Models, Animal; Fluorescent Antibody Techn

2006
Melatonin modulates signal transduction pathways and apoptosis in experimental colitis.
    Journal of pineal research, 2006, Volume: 41, Issue:4

    Topics: Animals; Apoptosis; Colitis; Cytokines; Dinitrofluorobenzene; Disease Models, Animal; JNK Mitogen-Ac

2006
Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
    Neuropharmacology, 2007, Volume: 52, Issue:2

    Topics: Analysis of Variance; Animals; Benzhydryl Compounds; Benzoates; Carrageenan; Dinucleoside Phosphates

2007
O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII.
    The AAPS journal, 2007, Jun-29, Volume: 9, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Binding Sites; Coagulants; Disease Models, Animal; Drug Stability;

2007
Phosphorylation-regulated cleavage of the reticulon protein Nogo-B by caspase-7 at a noncanonical recognition site.
    Proteomics, 2007, Volume: 7, Issue:24

    Topics: Amino Acid Sequence; Animals; Apoptosis; Caspase 7; Caspase Inhibitors; CDC2 Protein Kinase; CHO Cel

2007
Serine phosphate, threonine phosphate and gamma-carboxyglutamic acid in normal and experimentally induced, pathologically calcified rat skin (topical cutaneous calciphylaxis).
    Calcified tissue international, 1981, Volume: 33, Issue:2

    Topics: 1-Carboxyglutamic Acid; Animals; Calciphylaxis; Dihydrotachysterol; Disease Models, Animal; Female;

1981